Subscribe Now
  • Home
  • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Coins2Day 500
    • Coins2Day 500 U.S.
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
  • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  • Home
  • Latest
    • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Coins2Day 500
    • Coins2Day 500
    • Coins2Day 500 U.S.
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
  • Finance
    • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  1. home
  1. home
  2. Allergan

Allergan

Page 3 of 6

White tablets
Health

Teva Says Its Deal to Buy Allergan’s Generics Business Will Close ‘Any Time’

By Reuters
July 13, 2016
Carl Icahn Recently Bought a ‘Large Position’ in Allergan
Finance

Carl Icahn Recently Bought a ‘Large Position’ in Allergan

By Sy Mukherjee
May 31, 2016
CNBC Events
Finance

Tech Reporter

By Reuters and Coins2Day Editors
May 10, 2016
Stocks Close Sharply Lower As Oil Prices Continue Decline
Finance

These Biopharma Companies Are the World’s Top Shareholder Value Creators

By Sy Mukherjee
May 3, 2016
The CEO of Valeant Pharmaceuticals has suggested that Allergan is fat, overstaffed and ripe for big
Health

Allergan Struck a $3.3 Billion Alzheimer’s Drug Deal Right After Its Pfizer Merger Collapsed

By Sy Mukherjee
April 7, 2016
Pfizer In Merger Talks With Allergan PLC
Health

Pfizer and Allergan Scrap $160 Billion Deal

By Reuters
April 6, 2016
Pfizer In Merger Talks With Allergan PLC
Finance

Pfizer, Allergan to Mutually Terminate Merger

By Reuters
April 6, 2016
Pfizer Inc. Headquarters As They Agree To Combine With Allergan Plc In $160 Billion Deal
Finance

Wall Street Is Betting the Pfizer-Allergan Deal Won’t Happen

By Jen Wieczner
April 5, 2016
Pfizer Inc. Headquarters As They Agree To Combine With Allergan Plc In $160 Billion Deal
Leadership

Here’s Why Allergan Shares Are Tanking

By Reuters
April 5, 2016
Why Teva’s $40 Billion Deal for Allergan’s Generic Drugs Is Being Delayed
Health

Why Teva’s $40 Billion Deal for Allergan’s Generic Drugs Is Being Delayed

By Sy Mukherjee
March 16, 2016
Pfizer Inc. Headquarters As They Agree To Combine With Allergan Plc In $160 Billion Deal
Finance

Here’s How Much More Pfizer Could Save in Taxes With Allergan Deal

By Jen Wieczner
February 26, 2016
U.S. Multinationals in Puerto Rico
Health

Eli Lilly Just Lost the Latest Round in its Patent Battle

By Reuters
February 12, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Biotech Stocks Crashed and Nobody Knows Why

By Jen Wieczner
January 29, 2016
Inside Teva Pharmaceuticals Headquarters
Health

Celgene Settles U.S. Patent Litigation for Revlimid

By Reuters and Aaron Task
December 23, 2015
Pfizer Inc. Headquarters As They Agree To Combine With Allergan Plc In $160 Billion Deal
Finance

2015 Is Now the Biggest Year Ever for M&A

By Chris Matthews
December 4, 2015

Most Popular

  • Europe
    Americans have been quietly plundering Greenland for over 100 years, since a Navy officer chipped fragments off the...
    By Paul Bierman and The Conversation
  • Health
    The head of marketing at Slate posted on LinkedIn requesting cleaning services as a benefit at her company. The next...
    By Sydney Lake
  • Economy
    America’s $38 trillion national debt is so big the nearly $1 trillion interest payment will be larger than Medicare soon
    By Shawn Tully
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Coins2Day
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.